CDXC

Q: What is the price of ChromaDex (CDXC) today?

The current price of ChromaDex (CDXC) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does ChromaDex (CDXC) pay dividends?

ChromaDex (CDXC) did not pay dividends over the past year.

Q: Is ChromaDex (CDXC) a good investment?

ChromaDex (CDXC) is currently trading at $ 0.00 with a P/E ratio of 70.61%. This represents a 1,394% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

ChromaDex Corporation

This asset is no longer available for investment.

View all assets

Price

$ -

return (12m)

0.00%

p/e

70.61

p/bv

13.10

DIVIDEND YIELD

0.00%

CDXC price

CDXC

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment CDXC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals CDXC

review the fundamentals of ChromaDex shares

P/E

70.61

Sector: -2.14 Industry: -1.71

P/S (PSR)

6.06

Sector: 1.94 Industry: 0.71

P/BV

13.10

Sector: 2.13 Industry: 1.90

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

12.52%

Sector: -25.39% Industry: -14.37%

ROE

18.55%

Sector: -29.75% Industry: -28.71%

ROIC

358.81%

Sector: -418.64% Industry: -113.23%

NET MARGIN

8.59%

Sector: -27.73% Industry: -15.57%

GROSS MARGIN

61.84%

Sector: 44.91% Industry: 30.81%

OPERATING MARGIN

7.75%

Sector: -22.84% Industry: -7.79%

EV/EBITDA

65.55

Sector: -0.35 Industry: 0.83

EV/EBIT

78.20

Sector: -1.68 Industry: 2.65

PRICE-TO-ASSETS

8.84

Sector: 1.14 Industry: 0.84

BVPS

0.60

Sector: 3.83 Industry: 5.19

EPS

0.11

Sector: -0.89 Industry: -0.57

EQUITY-TO-ASSETS RATIO

0.68

Sector: 0.44 Industry: 0.27

LIABILITIES / ASSETS

0.32

Sector: 0.46 Industry: 0.48

CAGR REVENUE 5 YEARS

25.15%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF ChromaDex ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 0.00

Fair Value

$ 0.00

Upside/Downside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals CDXC

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	41.59	35.99	86.53%	0.65%	$ 858.38 B	31.66%
ISRG	56.96	9.07	15.92%	0.00%	$ 162.68 B	28.38%
TMO	27.82	3.48	12.52%	0.35%	$ 186.54 B	15.05%
SNY	12.68	1.38	10.86%	4.67%	$ 115.62 B	18.68%
NVS	21.29	6.40	30.04%	4.48%	$ 297.73 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.58	2.30	9.38%	2.41%	$ 113.37 B	13.00%
GSK	15.39	5.50	35.71%	3.00%	$ 117.42 B	17.48%
CVS	56.86	1.33	2.35%	3.36%	$ 100.53 B	0.44%
BSX	31.39	0.00	0.00%	0.00%	$ 90.98 B	14.44%
TMDX	19.73	7.94	40.22%	0.00%	$ 3.75 B	31.43%
HCA	17.15	-41.99	-244.82%	0.58%	$ 116.34 B	8.97%
IDXX	44.22	29.19	65.99%	0.00%	$ 46.85 B	24.62%
RMD	22.49	5.29	23.51%	1.02%	$ 33.42 B	27.53%
DHR	38.03	2.62	6.88%	0.66%	$ 137.43 B	14.71%
INMD	9.25	1.27	13.73%	0.00%	$ 868.14 M	25.32%
PHG	25.94	2.09	8.06%	3.13%	$ 26.91 B	5.07%
FMS	11.96	0.81	6.75%	3.34%	$ 13.50 B	5.02%
SYK	40.02	5.79	14.48%	1.00%	$ 129.89 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

CDXC Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT ChromaDex

ChromaDex Corporation

Average Investor10 user rating

4.0 (1 people)

United States

26 years

Founded: 2000

2008

Time since IPO - 18 years

110

Employees

ChromaDex Corporation (United States) is listed on the Nasdaq and has a market capitalization of $603.68 Millions, with shareholders equity totaling $46.09 Millions.

The company employs approximately 110 people and operates in the Health sector, within the Life Science Tools and Services industry.

Over the past 12 months, ChromaDex Corporation reported $99.59 Millions in revenue, generating net income of $8.55 Millions.

Key financial metrics include a P/E ratio of 70.61, a price-to-book (P/B) ratio of 13.10, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CDXC.

Market cap

$ 603.68 Millions

Net worth

$ 46.09 Millions

$ 46,090,000.00

Assets

$ 68.28 Millions

$ 68,280,000.00

Total Shares Outstanding

77.00 Millions

77,000,000

Average Daily Trading Volume

$ 862.25 Thousand

$ 862,250.94

Sector

Health

Industry

Life Science Tools and Services

CDXC

CDXC revenue and profits

Financial Results CDXC

DRAG THE FRAME TO SEE MORE DATA

CDXC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 74.99 14,53% (12M)

P/E

56.86

3.36%

ROE

2.35%

P/BV

1.33

CI - Cigna

$ 268.63 --16,73% (12M)

P/E

10.78

2.19%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 37.60 --39,34% (12M)

P/E

-2.75

0.00%

ROE

-33.28%

P/BV

0.91

HUM - Humana

$ 198.37 --29,22% (12M)

P/E

19.94

1.79%

ROE

6.70%

P/BV

1.34

HCA - HCA Healthcare

$ 488.58 48,62% (12M)

P/E

17.15

0.58%

ROE

-244.82%

P/BV

-41.99

LLY - Eli Lilly

$ 905.03 11,44% (12M)

P/E

41.59

0.65%

ROE

86.53%

P/BV

35.99

NVS - Novartis

$ 152.08 46,60% (12M)

P/E

21.29

4.48%

ROE

30.04%

P/BV

6.40